Research Reports

This study assessed the barriers and opportunities that exist in expanding Medication-Assisted Treatment (MAT) services in Pennsylvania. MAT includes the use of methadone, buprenorphine, Suboxone, naloxone, and naltrexone in residential, behavioral, or outpatient programs, hospitals, and jails and prisons to help individuals suffering from opioid addiction to overcome withdrawal symptoms, cravings, and potential overdose. The research found that those who seek emergency care and long-term treatment for opioids and who live in rural areas of Pennsylvania have limited access to care. Other barriers to accessing MAT services are lack of childcare and housing, lack of transportation, limited private insurance coverage, and limited funding for MAT services. Combating heroin and opioid use disorders requires an "all-in" commitment. It should continue to enforce laws and regulations enacted to provide coverage for mental health services for patients suffering from addiction and direct additional state and federal funding to support MAT services throughout Pennsylvania.